+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Colony Stimulating Factor"

Chemotherapy Induced Neutropenia Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Chemotherapy Induced Neutropenia Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 118 Pages
  • Global
From
Chemotherapy-Induced Neutropenia (CIN) Treatment Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027) - Product Thumbnail Image

Chemotherapy-Induced Neutropenia (CIN) Treatment Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 113 Pages
  • Global
From
Loading Indicator

Colony Stimulating Factor (CSF) is a type of drug used to treat immune disorders. It is a type of cytokine, a protein that helps regulate the immune system. CSF drugs are used to treat a variety of conditions, including neutropenia, anemia, and certain types of cancer. They can also be used to reduce the risk of infection in patients with weakened immune systems. CSF drugs work by stimulating the production of white blood cells, which help fight infection. CSF drugs are typically administered intravenously or subcutaneously. Common side effects include fever, chills, nausea, and headache. In some cases, CSF drugs can cause allergic reactions or anaphylaxis. The CSF market is a growing segment of the immune disorders drugs market. It is expected to continue to grow as more treatments become available and as the demand for immune-related treatments increases. Some companies in the CSF market include Amgen, Biogen, Celgene, and Novartis. Show Less Read more